2023-2025 Research Funding Competition

SCN’s national research funding competition supports world-class, translational, regenerative medicine research, across the research continuum, to facilitate health, social and economic benefits for Canadians.

The application process for Round 2 is now closed. The results of this research funding competition will be announced in spring 2023.

On September 1, the Stem Cell Network launched the second and final of two national research funding competitions planned for SCN’s 2022-2025 funding cycle. This new competition will support research activities during the 2023 to 2025 time period. Five regenerative medicine research programs are available that focus on innovation, clinical translation, policy and societal impact, and commercialization.

The results from SCN’s Round 1 2022-2025 competition, which offered two and three-year awards, were announced publicly on May 12, 2022, and can be found here.

The five programs are:

Impact Awards
SCN will provide up to $250,000 to support proof-of-principle experiments, including novel therapeutic or technical approach development that will drive regenerative medicine therapies forward.

Impact Awards: ELSI Stream 
SCN will provide up to $200,000 to support the knowledge generation and/or translation of regenerative medicine research for targeted stakeholders and/or users.

Accelerating Clinical Translation Award
SCN will provide up to $600,000 to support multi-disciplinary research that is moving towards the clinic within five years; or is addressing a key research question associated with an ongoing clinical trial.

Clinical Trial Awards
SCN will provide up to $750,000 to support early-stage clinical trial projects with high translational potential.

Fueling Biotechnology Partnerships Awards
SCN will provide up to $400,000 to support academic partnerships with emerging Canadian regenerative medicine biotechnology companies to bring innovative technologies or therapies to the clinic or market.